Literature DB >> 19448657

IL-17A directly inhibits TH1 cells and thereby suppresses development of intestinal inflammation.

Amit Awasthi1, Vijay K Kuchroo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19448657     DOI： 10.1038/ni0609-568

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  10 in total

1.  The mucosal milieu creates tolerogenic dendritic cells and T(R)1 and T(H)3 regulatory cells.

Authors:  H L Weiner
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

2.  A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.

Authors:  Richard H Duerr; Kent D Taylor; Steven R Brant; John D Rioux; Mark S Silverberg; Mark J Daly; A Hillary Steinhart; Clara Abraham; Miguel Regueiro; Anne Griffiths; Themistocles Dassopoulos; Alain Bitton; Huiying Yang; Stephan Targan; Lisa Wu Datta; Emily O Kistner; L Philip Schumm; Annette T Lee; Peter K Gregersen; M Michael Barmada; Jerome I Rotter; Dan L Nicolae; Judy H Cho
Journal:  Science       Date:  2006-10-26       Impact factor: 47.728

Review 3.  Induction and effector functions of T(H)17 cells.

Authors:  Estelle Bettelli; Thomas Korn; Mohamed Oukka; Vijay K Kuchroo
Journal:  Nature       Date:  2008-06-19       Impact factor: 49.962

4.  CD45RBhigh CD4+ T cells from IFN-gamma knockout mice do not induce wasting disease.

Authors:  H Ito; C G Fathman
Journal:  J Autoimmun       Date:  1997-10       Impact factor: 7.094

Review 5.  Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation.

Authors:  Ana Izcue; Janine L Coombes; Fiona Powrie
Journal:  Immunol Rev       Date:  2006-08       Impact factor: 12.988

6.  IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6.

Authors:  David Yen; Jeanne Cheung; Heleen Scheerens; Frédérique Poulet; Terrill McClanahan; Brent McKenzie; Melanie A Kleinschek; Alex Owyang; Jeanine Mattson; Wendy Blumenschein; Erin Murphy; Manjiri Sathe; Daniel J Cua; Robert A Kastelein; Donna Rennick
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

7.  Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces.

Authors:  Yuri P Rubtsov; Jeffrey P Rasmussen; Emil Y Chi; Jason Fontenot; Luca Castelli; Xin Ye; Piper Treuting; Lisa Siewe; Axel Roers; William R Henderson; Werner Muller; Alexander Y Rudensky
Journal:  Immunity       Date:  2008-04       Impact factor: 31.745

8.  A protective function for interleukin 17A in T cell-mediated intestinal inflammation.

Authors:  William O'Connor; Masahito Kamanaka; Carmen J Booth; Terrence Town; Susumu Nakae; Yoichiro Iwakura; Jay K Kolls; Richard A Flavell
Journal:  Nat Immunol       Date:  2009-06       Impact factor: 25.606

9.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

10.  T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17.

Authors:  Manu Rangachari; Nora Mauermann; René R Marty; Stephan Dirnhofer; Michael O Kurrer; Vukoslav Komnenovic; Josef M Penninger; Urs Eriksson
Journal:  J Exp Med       Date:  2006-07-31       Impact factor: 14.307
  10 in total
  18 in total

Review 1.  Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases.

Authors:  Mei Lan Chen; Mark S Sundrud
Journal:  Inflamm Bowel Dis       Date:  2016-05       Impact factor: 5.325

Review 2.  Current and emerging therapeutic targets for IBD.

Authors:  Markus F Neurath
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-02-01       Impact factor: 46.802

Review 3.  Immunopathology of inflammatory bowel disease.

Authors:  Kori L Wallace; Li-Bo Zheng; Yoshitake Kanazawa; David Q Shih
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

Review 4.  Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease.

Authors:  Reiko M Onishi; Sarah L Gaffen
Journal:  Immunology       Date:  2010-03       Impact factor: 7.397

Review 5.  T lymphocytes in the intestinal mucosa: defense and tolerance.

Authors:  Hongdi Ma; Wanyin Tao; Shu Zhu
Journal:  Cell Mol Immunol       Date:  2019-02-20       Impact factor: 11.530

Review 6.  IL-17 signaling in host defense and inflammatory diseases.

Authors:  Youcun Qian; Zizhen Kang; Caini Liu; Xiaoxia Li
Journal:  Cell Mol Immunol       Date:  2010-05-31       Impact factor: 11.530

7.  Secretion of IFN-gamma but not IL-17 by CD1d-restricted NKT cells enhances rejection of skin grafts expressing epithelial cell-derived antigen.

Authors:  Stephen R Mattarollo; Michelle Yong; Lieven Tan; Ian H Frazer; Graham R Leggatt
Journal:  J Immunol       Date:  2010-04-21       Impact factor: 5.422

8.  Inhibition of the K+ channel KCa3.1 ameliorates T cell-mediated colitis.

Authors:  Lie Di; Shekhar Srivastava; Olga Zhdanova; Yi Ding; Zhai Li; Heike Wulff; Maria Lafaille; Edward Y Skolnik
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-08       Impact factor: 11.205

9.  Critical role of Th17 responses in a murine model of Neisseria gonorrhoeae genital infection.

Authors:  B Feinen; A E Jerse; S L Gaffen; M W Russell
Journal:  Mucosal Immunol       Date:  2010-01-27       Impact factor: 7.313

10.  Distinct roles of interleukin-17 and T helper 17 cells among autoimmune diseases.

Authors:  Shintaro Akiyama; Atsushi Sakuraba
Journal:  J Transl Autoimmun       Date:  2021-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.